Exploring blood vessel side effects of immunotherapy
Part of Heart & circulation clinical trials.
This study looks at blood vessel problems that may happen when people take immunotherapy (a type of cancer treatment that helps your immune system fight cancer). If you join, doctors will watch for these side effects and learn more about how to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently being treated with an immunotherapy drug (such as nivolumab, pembrolizumab, or atezolizumab)
- You have not had immunotherapy in the past
- You have not had chemotherapy or targeted therapy in the last 4 weeks
- You do not have severe peripheral artery disease or severe Raynaud's syndrome
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early “predictive clues” (often blood or test markers) that can forecast immune-related side effects in people treated with immune checkpoint medicines. The goal is to help doctors recognize who may be more likely to have these side effects while receiving treatment.
This study looks at reports from large health databases to find out if certain cancer drugs (checkpoint inhibitors) cause heart problems. It aims to understand which patients have a higher risk, which may help doctors watch for heart issues in the future.
This trial looks at a faster heart and blood-vessel assessment for people who are taking immune cancer drugs and have been referred because they might be having a heart-related side effect. It may help by speeding up evaluation and treatment decisions when symptoms raise concern.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
This study collects blood, stool, and tissue samples from people who have had side effects from immunotherapy (a type of cancer treatment that helps your immune system fight cancer). It aims to learn more about these side effects, so doctors can better manage them in the future.
This study looks at how immune-related side effects happen in people treated with certain cancer immunotherapies. It also includes some healthy volunteers and people who already have similar autoimmune conditions, to better understand and compare these reactions.
Hear when a new Vascular Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.